Thoracic Spinal Cord Stimulation Improves Cardiac Contractile Function and Myocardial Oxygen Consumption in a Porcine Model of Ischemic Heart Failure

2011 ◽  
Vol 23 (5) ◽  
pp. 534-540 ◽  
Author(s):  
YUAN LIU ◽  
WEN-SHENG YUE ◽  
SONG-YAN LIAO ◽  
YUELIN ZHANG ◽  
KA-WING AU ◽  
...  
2013 ◽  
Vol 30 (3) ◽  
pp. 142-159 ◽  
Author(s):  
Jae H. T. Lee ◽  
Claire F. Jones ◽  
Elena B. Okon ◽  
Lisa Anderson ◽  
Seth Tigchelaar ◽  
...  

2018 ◽  
Vol 32 (S1) ◽  
Author(s):  
Erica A. Dale ◽  
Jasmine P. Kipke ◽  
Michael D. Sunshine ◽  
Yukiko Kubo ◽  
Peter A. Castro ◽  
...  

BMC Genomics ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Adam Doelman ◽  
Seth Tigchelaar ◽  
Brian McConeghy ◽  
Sunita Sinha ◽  
Martin S. Keung ◽  
...  

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Zhonggang Li ◽  
Quanjiang Zhang ◽  
Karla Pires ◽  
E. Dale Abel

Autophagy is an essential process that maintains cellular homeostasis via lysosomal degradation pathways. Autophagy has been found to be involved in various pathophysiological conditions in the heart, including myocardial hypertrophy and ischemic heart disease. However, the precise mechanism by which autophagy maintains cardiac function in the non-stressed heart is incompletely understood. We generated cardiac-specific ATG3 deficient mice (cATG3 KO mice) by crossing αMHC-Cre mice with floxed ATG3 mice. Relative to their wild type (WT) littermates, cATG3 KO mice revealed reduced ATG3 expression and inhibited autophagy specifically in the heart. At 4 months of age, cATG3 KO mice showed impaired cardiac contractile function, characterized by a 25% reduction in fractional shortening by echocardiography (p <0.01), Moreover, cATG3 KO mice revealed increased lipid accumulation, reduced fatty acid oxidation and impaired mitochondrial respirations in the heart, without evidence of fibrosis or inflammation. Mitochondrial dysfunction in cATG3 KO mice was accompanied with mitochondrial content loss and reduced expression of mitochondrial biogenesis related genes (PGC1α, NRF1, NRF2 and TFAM). Interestingly, autophagy inhibition, induced mitochondrial biogenesis defects and mitochondrial dysfunction in neonatal cATG3 KO mice (1 week old), prior to the onset of cardiac contractile dysfunction and heart failure, suggesting that cardiac mitochondrial dysfunction may be an early event in the progression of heart failure in the autophagy deficient mice. Finally, in response to exercise training mitochondrial biogenesis (PGC1 alpha induction and increased respiration rates) was completely inhibited in ATG3 deficient mice. In conclusion, autophagy is essential for generating signals that promote mitochondrial biogenesis, and is indispensable for normal heart function under basal conditions.


Heart Rhythm ◽  
2015 ◽  
Vol 12 (3) ◽  
pp. 588-595 ◽  
Author(s):  
Hung-Fat Tse ◽  
Stuart Turner ◽  
Prashanthan Sanders ◽  
Yuji Okuyama ◽  
Katsuhito Fujiu ◽  
...  

2020 ◽  
Vol 598 (5) ◽  
pp. 929-942 ◽  
Author(s):  
Christopher R. West ◽  
Malihe‐Sadat Poormasjedi‐Meibod ◽  
Neda Manouchehri ◽  
Alexandra M. Williams ◽  
Erin L. Erskine ◽  
...  

2020 ◽  
Vol 319 (4) ◽  
pp. C694-C699
Author(s):  
Sophie I. Hamstra ◽  
Kennedy C. Whitley ◽  
Ryan W. Baranowski ◽  
Nigel Kurgan ◽  
Jessica L. Braun ◽  
...  

Cardiac contractile function is largely mediated by the regulation of Ca2+ cycling throughout the lifespan. The sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) pump is paramount to cardiac Ca2+ regulation, and it is well established that SERCA dysfunction pathologically contributes to cardiomyopathy and heart failure. Phospholamban (PLN) is a well-known inhibitor of the SERCA pump and its regulation of SERCA2a—the predominant cardiac SERCA isoform—contributes significantly to proper cardiac function. Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase involved in several metabolic pathways, and we and others have shown that it regulates SERCA function. In this mini-review, we highlight the underlying mechanisms behind GSK3’s regulation of SERCA function specifically discussing changes in SERCA2a and PLN expression and its potential protection against oxidative stress. Ultimately, these recent findings that we discuss could have clinical implications in the treatment and prevention of cardiomyopathies and heart failure.


Circulation ◽  
2005 ◽  
Vol 111 (24) ◽  
pp. 3217-3220 ◽  
Author(s):  
Ziad F. Issa ◽  
Xiaohong Zhou ◽  
Michael R. Ujhelyi ◽  
Josh Rosenberger ◽  
Deepak Bhakta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document